Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
Clinical trial NCT07333274 · RECRUITING
Trial details
- NCT number
- NCT07333274
- Sponsor
- Shandong Cancer Hospital and Institute
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-05
- Primary completion
- 2028-01-05
- Enrollment
- 335
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.